DrugPatentWatch Database Preview
Biomarin Pharm Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for BIOMARIN PHARM, and what generic alternatives to BIOMARIN PHARM drugs are available?
BIOMARIN PHARM has two approved drugs.
There are eleven US patents protecting BIOMARIN PHARM drugs.
There are eighty patent family members on BIOMARIN PHARM drugs in twenty-four countries.
Summary for Biomarin Pharm
| International Patents: | 80 |
| US Patents: | 11 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
| Patent Litigation for Biomarin Pharm: | See patent lawsuits for Biomarin Pharm |
Drugs and US Patents for Biomarin Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | RX | Yes | Yes | 9,433,624 | Start Trial | Start Trial | ||||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | RX | Yes | Yes | 8,003,126*PED | Start Trial | Y | Start Trial | |||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | RX | Yes | Yes | 7,566,462*PED | Start Trial | Y | Start Trial | |||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | POWDER;ORAL | 205065-001 | Dec 19, 2013 | AB | RX | Yes | Yes | 8,067,416*PED | Start Trial | Y | Start Trial | ||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | RX | Yes | Yes | 7,947,681*PED | Start Trial | Y | Start Trial | |||
| Biomarin Pharm | KUVAN | sapropterin dihydrochloride | TABLET;ORAL | 022181-001 | Dec 13, 2007 | RX | Yes | Yes | 8,067,416*PED | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for BIOMARIN PHARM drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2014-05-30 |
| ➤ Subscribe | Powder for Oral Solution | 500 mg/packet | ➤ Subscribe | 2016-12-20 |
| ➤ Subscribe | Powder for Oral Solution | 100 mg per packet | ➤ Subscribe | 2015-11-09 |
International Patents for Biomarin Pharm Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2596827 | Start Trial |
| China | 1905863 | Start Trial |
| Japan | 2011162568 | Start Trial |
| Japan | 2011508775 | Start Trial |
| Israel | 201101 | Start Trial |
| Poland | 1708690 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
